EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 194 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Perioperative Durvalumab Plus FLOT Improves OS in Patients with Resectable Gastric or GEJ Adenocarcinoma Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML MOST POPULAR Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context May 22, 2026 The Pesticide Chemical Responsible For Mass Bee Die-Offs Is Killing Birds... August 20, 2020 This Bar of Soap with a Lump Will Help You Remember... May 31, 2019 Palliative and Supportive Care for Children With Cancer: An Expert Perspective October 5, 2023 Load more HOT NEWS An unexpected find: clues about the genetics of children’s cancer found... ‘Being open will help bring awareness’: Meet the fashion vlogger who... Woman Showed Up To Their Wedding And Stole All Their Gifts.... FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic...
